Dr. Lal PathLabs539524Stake acquisition deal
Dr. Lal PathLabs: PathLabs Unifiers buys remaining 30% of Centrapath Labs at INR 1608.352 per share, CPL now wholly owned
By ScoutQuest · · 1 min read
30%Equity stake acquired in CPL
- Stake Acquired
- Remaining 30% equity stake in Centrapath Labs Private Limited
- Consideration per Share
- INR 1608.352 per share in cash
- Acquisition Date
- October 13, 2026
- Target
- Centrapath Labs Private Limited (CPL)
- Transaction
- Acquisition of remaining stake in a subsidiary
Dr. Lal PathLabs: PathLabs Unifiers buys remaining 30% of Centrapath Labs at INR 1608.352 per share, CPL now wholly owned.
20.5 Crores-13.5%
FY202523.7 CroresFY202620.5 Crores
CPL incorporated
Prior intimation
Acquisition completed
Also from Dr. Lal PathLabs
Dr Lal PathLabs completed acquisition of the remaining 30% stake in Suburban Diagnostics (Straterpath Labs) at over Rs 1,600 per share
14 Oct 2026
Dr. Lal PathLabs invests up to INR 30.3 crore in WOS PathLabs Unifiers to fund buyout of remaining 30% of CentraPath Labs
12 Oct 2026
Income Tax Dept appeals before ITAT against relief on ESOP expense disallowance
8 Oct 2026
More numbers
- CPL turnover FY 202620.5 Crores
- CPL turnover FY 202523.7 Crores
- CPL turnover FY 202420.8 Crores
- Equity stake acquired in CPL30%
- Price per share paid by PUPLINR 1608.352
Source: BSE · 13 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.